Jazz Pharmaceuticals Plc (JAZZ)
254.34
+0.06
(+0.02%)
USD |
NASDAQ |
Aug 24, 16:00
257.70
+3.36
(+1.32%)
After-Hours: 20:00
Jazz Pharmaceuticals Total Liabilities (Quarterly) : 6.279B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.279B |
| March 31, 2026 | 7.327B |
| December 31, 2025 | 7.341B |
| September 30, 2025 | 7.397B |
| June 30, 2025 | 7.238B |
| March 31, 2025 | 7.360B |
| December 31, 2024 | 7.919B |
| September 30, 2024 | 8.085B |
| June 30, 2024 | 7.599B |
| March 31, 2024 | 7.631B |
| December 31, 2023 | 7.656B |
| September 30, 2023 | 7.715B |
| June 30, 2023 | 7.735B |
| March 31, 2023 | 7.712B |
| December 31, 2022 | 7.750B |
| September 30, 2022 | 7.639B |
| June 30, 2022 | 7.999B |
| March 31, 2022 | 8.160B |
| December 31, 2021 | 8.333B |
| September 30, 2021 | 8.540B |
| June 30, 2021 | 9.082B |
| March 31, 2021 | 2.959B |
| December 31, 2020 | 2.876B |
| September 30, 2020 | 2.915B |
| June 30, 2020 | 2.925B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.407B |
| December 31, 2019 | 2.428B |
| September 30, 2019 | 2.473B |
| June 30, 2019 | 2.505B |
| March 31, 2019 | 2.550B |
| December 31, 2018 | 2.446B |
| September 30, 2018 | 2.458B |
| June 30, 2018 | 2.479B |
| March 31, 2018 | 2.501B |
| December 31, 2017 | 2.411B |
| September 30, 2017 | 2.530B |
| June 30, 2017 | 2.603B |
| March 31, 2017 | 2.832B |
| December 31, 2016 | 2.923B |
| September 30, 2016 | 3.215B |
| June 30, 2016 | 1.756B |
| March 31, 2016 | 1.928B |
| December 31, 2015 | 1.734B |
| September 30, 2015 | 1.901B |
| June 30, 2015 | 1.946B |
| March 31, 2015 | 1.932B |
| December 31, 2014 | 1.968B |
| September 30, 2014 | 2.007B |
| June 30, 2014 | 1.876B |
| March 31, 2014 | 1.930B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 101.22M |
| Perrigo Co. Plc | 5.094B |
| GH Research Plc | 12.86M |
| Cosmo NV | -- |
| Liquidia Corp. | 326.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.08B |
| Shareholders Equity (Quarterly) | 4.802B |
| Debt to Equity Ratio | 0.9183 |
| Current Ratio | 1.779 |
| Net Debt Paydown Yield | 1.29% |